Philippe Sauthier

Centre Hospitalier de l’Université de Montréal

Papers

1

Total Citations

84

H-Index

1

About

Philippe Sauthier is a leading figure in gynecologic oncology, with a focused expertise in sentinel lymph node mapping for endometrial cancer. His most impactful work, a landmark randomized controlled trial comparing indocyanine green (ICG) to methylene blue, has garnered 84 citations and fundamentally shifted clinical practice. This study demonstrated ICG’s superior detection rates, establishing it as the preferred tracer for minimally invasive staging. Sauthier’s contributions have directly improved the precision of lymphatic mapping, reducing the morbidity of full lymphadenectomy while enhancing diagnostic accuracy. His research bridges surgical innovation and patient-centered outcomes, offering a paradigm for evidence-based adoption of new technologies. Beyond this pivotal trial, his work continues to influence guidelines for endometrial cancer management, cementing his reputation as a pragmatic innovator in the field. For students and researchers, Sauthier exemplifies how a single, well-designed study can reshape surgical standards and improve cancer care.

Research Focus

Key Achievements

1
H-Index
1
Papers
84
Total Citations
84
Avg Citations/Paper
🏆 Most Cited Paper
Green versus blue: Randomized controlled trial comparing indocyanine green with methylene blue for sentinel lymph node detection in endometrial cancer
84 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Centre Hospitalier de l’Université de Montréal

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago